IVX 0.00% 0.4¢ invion limited

Invex Therapeutics (ASX:IVX)Invex has received an approval from...

  1. 31 Posts.
    lightbulb Created with Sketch. 5
    Invex Therapeutics (ASX:IVX)
    Invex has received an approval from the UK’s MHRA to commence its IIH EVOLVE Phase III clinical trial in the country. The trial will study patients with Idiopathic Intracranial Hypertension (IIH), and they will be randomly treated with Presendin versus placebo once weekly over 24 weeks.
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $26.41M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $72 18K

Buyers (Bids)

No. Vol. Price($)
25 10334314 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 6053724 25
View Market Depth
Last trade - 15.42pm 12/07/2024 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.